Convalescent Plasma Therapy: An aspiring option for COVID-19 treatment?

Haematology Journal of Bangladesh

View Publication Info
Field Value
Title Convalescent Plasma Therapy: An aspiring option for COVID-19 treatment?
Creator Biswas, Akhil Ranjon
Rahman, Md. Mahbubur
Subject COVID-19
Convalescent Plasma Therapy
Description COVID-19 is a cause of life threating severe acute respiratory syndrome (SARS) caused by a novel corona virus named as SARS-Cov-2. Since it has 1st been identified in the city of Wuhan in China in December, 2019, it has spread rapidly all over the world. As it is a newly emerged viral infection and any vaccine or specific therapy yet to be proven as clearly effective, multiple therapeutic option with supportive intent as well as search for specific therapy to combat the virus are under vigorous trial around the world. Convalescent plasma therapy is one such investigational therapeutic option for COVID-19 with hope that neutralizing antibodies present in plasma of persons recovered from COVID-19 would be able to neutralize the virus in infected person.
Publisher Haematology Society of Bangladesh
Date 2020-12-31
Type info:eu-repo/semantics/article
Format text/html
Source Haematology Journal of Bangladesh; Vol. 4 No. 02 (2020); 52-56
Language eng
Rights Copyright (c) 2020 Akhil Ranjon Biswas, Md. Mahbubur Rahman

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library